Physician profile
Julienne Lippe
NPI 1861610743
$6,305.91
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,809 · 2020: $1,106 · 2021: $218 · 2022: $172.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $4,490.47 | 2019-2021 | |
| Stryker Corporation | $1,431.20 | 2019-2022 | |
| Smith+Nephew, INC. | $105.54 | 2021-2022 | |
| Pacira Therapeutics, INC. | $87.54 | 2019-2021 | |
| Depuy Synthes Sales INC. | $72.84 | 2019-2020 | |
| Wright Medical Technology, INC. | $49.09 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $16.99 | 2019 | |
| Vericel Corporation | $13.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julienne Lippe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.